Vitiligo is an acquired chronic depigmenting disorder of the skin, with an estimated
prevalence of 0.5% of the general population, characterized by the development of white …

The pathophysiology of vitiligo is becoming increasingly clarified. In non-segmental vitiligo,
early factors include activation of innate immunity, inflammasome activation, oxidative stress …

British Association of Dermatologists guidelines for the management of people with vitiligo 2021*
| British Journal of Dermatology | Oxford Academic Skip to Main Content Advertisement intended …

Vitiligo is a common skin disorder characterized by immune‐mediated destruction of
melanocytes. Non‐segmental vitiligo, the most common clinical subtype, has usually a …

Vitiligo is a chronic autoimmune disease characterized by loss of pigment of the skin,
affecting 0.5–2% of the population worldwide. It can have a significant impact on patients' …

Vitiligo is an asymptomatic but cosmetically disfiguring disorder that results in the formation
of depigmented patches on skin and/or mucosae. Vitiligo can be segmental or non …

Vitiligo is a chronic pigmentary skin disorder that results in white, hypopigmented macules
and patches. It causes a considerable psychological and emotional burden on the affected …

Aims and objectives The purpose of this study is to investigate the effectiveness and safety
of oral and injectable systemic treatments, such as methotrexate, azathioprine, cyclosporine …

Background NB‐UVB has long been the vitiligo management pillar with capability of
achieving the main treatment outcomes; repigmentation and stabilization. Its stabilizing …

Background: Vitiligo is a muco-cutaneous, autoimmune, localized, or disseminated disease,
which manifests through hypochromic or achromic macules, with loss in quality of life. The …